Immediate Impact
1 by Nobel laureates 60 standout
Citing Papers
Development of an mRNA-lipid nanoparticle vaccine against Lyme disease
2023 StandoutNobel
Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance
2022 Standout
Works of E. Lebacq being referenced
Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15–25 years
2008
Comparative Tolerability and Immunogenicity of Typherix??? or Typhim Vi??? in Healthy Adults*
2001
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| E. Lebacq | 16 | 173 | 77 | 101 | 78 | 13 | 345 | |
| Janné Croll | 183 | 81 | 166 | 73 | 14 | 400 | ||
| Forrest Smith | 20 | 128 | 148 | 120 | 30 | 13 | 388 | |
| Shyam Bawikar | 2 | 165 | 89 | 131 | 40 | 18 | 334 | |
| C. Roure | 2 | 194 | 30 | 139 | 36 | 22 | 354 | |
| Gro Njølstad | 2 | 175 | 35 | 92 | 10 | 15 | 345 | |
| Raid Kayouf | 2 | 204 | 9 | 88 | 42 | 13 | 308 | |
| Kristina Elfving | 4 | 144 | 28 | 89 | 23 | 23 | 400 | |
| Houda Harastani | 11 | 312 | 30 | 77 | 13 | 20 | 408 | |
| A. A. Ferris | 3 | 102 | 14 | 235 | 13 | 25 | 340 | |
| Michelle Dickey | 3 | 221 | 37 | 189 | 12 | 15 | 373 |
All Works
Loading papers...